LinkedIn
Twitter
Contact
Menu
Company
Overview
Management Team
Board of Directors
Scientific Advisory Board
Partnering
Careers
Pipeline
Overview
Sparsentan
RE-024
Liquid Ursodeoxycholic Acid
RE-034 & Discovery Programs
Products
Overview
THIOLA® (tiopronin) tablets
CHOLBAM® (cholic acid) capsules
CHENODAL® (Chenodiol Tablets 250 mg)
Patients
Overview
Our Therapeutic Focus
FSGS
PKAN
Primary Biliary Cholangitis
CTX
NGLY1 Deficiency
Cystinuria
Bile Acid Synthesis Disorders and Zellweger Spectrum Disorders
Access to Our Therapies
Healthcare Professionals
Overview
Research & Educational Support
Clinical Trials
Genetic Testing
CTX Prevalence Study
Investors & Media
Investor Relations
Press Releases
Events & Presentations
Management & Directors
Governance Documents
Financial Information
Stock Information
Investor FAQs
Contact Us
Contact
View:
All Filings
All Filings (excluding Section 16)
Annual
Quarterly
Current
Section 16
Proxy
Other
Sort By:
Date Descending
Date Ascending
Filing Descending
Filing Ascending
Description Descending
Description Ascending
Update
There are no filings available.
Shareholder Tools
Facebook
Google
LinkedIn
Twitter
Email
RSS
Facebook
Google
LinkedIn
Twitter
Email
RSS
